AbbVie Korea announced that the Ministry of Food and Drug Safety (MFDS) has approved an expanded indication for its ...
AITRICS, a Korean medical AI company, said Tuesday that its research on deep learning models for predicting the risk of acute ...
EuBiologics said it has completed the Clinical Study Report (CSR) for the phase 1 trial of its investigational respiratory ...
Bayer has brought its global startup incubation program to Korea, giving seven early-stage biotech companies direct guidance ...
Body mass index (BMI) alone is insufficient to diagnose obesity in Asian populations, according to an international team of ...
AriBio has completed the pivotal global phase 3 clinical trial of its oral Alzheimer's disease drug candidate AR1001, ...
Expanding the role of alpha-fetoprotein (AFP) blood testing alongside ultrasound in Korea's national liver cancer screening ...
Dry, gritty eyes are commonly attributed to dry eye syndrome, but in some cases they may be a sign of Sjögren's syndrome ...
The government has expanded its National Immunization Program (NIP) support for hematopoietic stem cell transplant (HSCT) ...
K-Hospital Healthtech Fair (KHF) 2026 will feature 32 seminars and conferences on hospital AI transformation, digital ...
Talos, a Korean developer of AI-based cerebrovascular disease risk prediction software, aims to make brain aneurysm risk ...
NEXT BIOMEDICAL has completed the U.S. FDA's pre-submission process for its vascular embolization device Nexsphere-F under the agency's Total Product Lifecycle Advisory Program (TAP) after receiving f ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results